Implantable or insertable medical devices for controlled drug delivery

• US 8,691,264 B2
• Filed: 02/24/2012
• Issued: 04/08/2014
• Est. Priority Date: 02/08/2002
• Status: Expired due to Fees

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Inventors: Li, Jianmin, Conley, Danielle, Bucay-Couto, Weenna, Dao, Cang Duy, Davoudi, Hamid, Lareau, Raymond J., Miller, Kathleen M
• Primary Examiner(s): AZPURU, CARLOS A
• Application Number:
  US13/404,832
• Publication Number:
  US 20120150096A1
• Time in Patent Office: 774 Days
• Field of Search: None
• US Class Current: 424/426
• CPC Class Codes: A61F 2002/072 Encapsulated stents, e.g. wire or whole stent embedded in lining
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body
• CPC Class Codes: A61K 9/0024 Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L
• CPC Class Codes: A61K 9/2027 obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
• CPC Class Codes: A61L 2/232 layered or coated
• CPC Class Codes: A61L 2300/40 characterised by a specific therapeutic activity or mode of action
• CPC Class Codes: A61L 2300/402 Anaestetics, analgesics, e.g. lidocaine
• CPC Class Codes: A61L 2300/404 Biocides, antimicrobial agents, antiseptic agents
• CPC Class Codes: A61L 2300/41 Anti-inflammatory agents, e.g. NSAIDs
• CPC Class Codes: A61L 2300/602 Type of release, e.g. controlled, sustained, slow
• CPC Class Codes: A61L 29/16 Biologically active materials, e.g. therapeutic substances A61L29/048 takes precedence
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence
• CPC Class Codes: A61L 31/18 Materials at least partially X-ray or laser opaque
• CPC Class Codes: A61M 31/002 Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50
• CPC Class Codes: A61P 13/02 of urine or of the urinary tract, e.g. urine acidifiers
• CPC Class Codes: A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Implantable or insertable medical devices are provided, which comprises: (a) a biocompatible polymer; and (b) at least one therapeutic agent selected from an anti-inflammatory agent, an analgesic agent, an anesthetic agent, and an antispasmodic agent. The medical devices are adapted for implantation or insertion at a site associated with pain or discomfort upon implantation or insertion. In many embodiments, the therapeutic will be selected from at least one of (i) ketorolac and pharmaceutically acceptable salts thereof (e.g., ketorolac tromethamine) and (ii) 4-diethylamino-2-butynylphenylcyclohexyl glycolate and pharmaceutically acceptable salts thereof (e.g., oxybutynin chloride). Also provided are uses for the implantable or insertable medical devices, which uses comprise reducing pain or discomfort accompanying the implantation or insertion of such devices. Further uses may comprise reducing microbial buildup along the device. Methods for manufacturing implantable or insertable medical devices are also provided.

Claims

1. An implantable or insertable medical device comprising:

(a) an extruded first biocompatible matrix polymer region that comprises a matrix polymer and at least one therapeutic agent and (b) a coextruded second biocompatible matrix polymer region that comprises a matrix polymer and at least one therapeutic agent, wherein one of the matrix polymers comprises a non-biodegradable polymer and another of the matrix polymers comprises a biodegradable polymer.

2. The medical device of claim 1, wherein said non-biodegradable polymer is selected from the group consisting of ethylene vinyl acetate copolymers, copolymers of ethylene with acrylic acid or methacrylic acid, elastomeric polyurethanes and polyurethane copolymers, metallocene catalyzed polyethylene, ionomers and vinyl aromatic copolymers.

3. The medical device of claim 1, wherein said biodegradable polymer is selected from the group consisting of polylactic acid, polyglycolic acid, and copolymers and mixtures thereof.

4. The medical device of claim 1, wherein said non-biodegradable polymer is an ethylene vinyl acetate copolymer.

5. The medical device of claim 1, wherein at least one biocompatible matrix polymer region comprises a radio-opacifying agent.

6. The medical device of claim 5, wherein said radio-opacifying agent comprises bismuth subcarbonate.

7. The medical device of claim 1, at least one therapeutic agent is selected from the group consisting of chemotherapeutic agents, NSAIDs, steroidal anti-inflammatory agents, and mixtures thereof.

8. The medical device of claim 1, further comprising one or more barrier layers at least partially covering said at least one matrix polymer region.

9. The medical device of claim 1, a first polymeric barrier layer at least partially covering an interior surface of said first biocompatible matrix polymer region;

and a second polymeric barrier layer at least partially covering an exterior surface of said first biocompatible matrix polymer region.

10. The medical device of claim 9, wherein each of said first biocompatible matrix polymer region, and said first and second polymeric barrier layers is in the form of an annulus.

11. The medical device of claim 9, wherein the first and second polymeric barrier layers comprise the same polymeric materials.

12. The medical device of claim 9, wherein the first and second polymeric barrier layers comprise different polymeric materials.

13. The medical device of claim 9, further comprising a second and, optionally, a third biocompatible matrix polymer region and a third and, optionally, a fourth polymeric barrier layer;

wherein the second biocompatible matrix polymer region is disposed on an outside surface of the second polymeric barrier layer and the third polymeric barrier layer at least partially covers an exterior surface of said second biocompatible matrix polymer region; and

, wherein the third biocompatible matrix polymer region, when present, is disposed on an interior surface of said first polymeric barrier layer and the fourth polymeric barrier layer at least partially covers an interior surface of said third biocompatible matrix polymer region.

14. The medical device of claim 1, wherein the first biocompatible matrix polymer region comprises an ethylene vinyl acetate copolymer.

15. The medical device of claim 9, wherein each of the first and second polymeric barrier layers comprises a material selected from the group consisting of metallocene catalyzed polyethylenes and polyethylene copolymers, ionomers, elastomeric polyurethanes and polyurethane copolymers, ethylene vinyl acetate copolymers and copolymers of ethylene with acrylic acid or methacrylic acid.

16. The medical device of claim 1, wherein the medical device is selected from the group consisting of a stent cover, a biliary stent, a ureteral stent, a pancreatic stent, a urinary catheter, a venous access device, a peritoneal access device, a device connecting or providing drainage between two sterile body environments, and a device connecting or providing drainage between a non-sterile and a sterile body environment.

17. The medical device of claim 16, wherein the device comprises a device connecting or providing drainage between a non-sterile and a sterile body environment.

18. The medical device of claim 16, wherein the device comprises a stent cover comprising a hollow tubular structure adapted to be placed over a stent that comprises a woven, knitted or braided open mesh design comprising a biocompatible material selected from the group consisting of stainless steel or a shape memory material.

19. The medical device of claim 8, wherein at least one of said one or more barrier layers comprises a biodegradable polymer.

20. The medical device of claim 19, where said biodegradable polymer is selected from the group consisting of polylactic acid, polyglycolic acid and copolymers and mixtures thereof.

21. An implantable or insertable medical device comprising:

(a) a first extruded polymeric matrix region comprising a first biocompatible polymer and a therapeutic agent, and (b) a second extruded polymer matrix region comprising a second biocompatible polymer and a radio-opacifying agent, wherein said first and second biocompatible polymers may be the same or different.

22. An implantable or insertable medical device comprising:

a single-layer matrix polymer structure formed from a mixture comprising an extruded polymeric matrix region comprising (a) a biocompatible polymer, (b) a radio-opacifying agent, and (c) at least one therapeutic agent, wherein said medical device is adapted for implantation or insertion at a site that is associated with pain or discomfort upon implantation or insertion.